Prashant Kohli - 09 Sep 2022 Form 3 Insider Report for Acasti Pharma Inc. (GRCE)

Role
CCO
Signature
/s/ Jason Comerford, Attorney-in-Fact
Issuer symbol
GRCE
Transactions as of
09 Sep 2022
Net transactions value
$0
Form type
3
Filing time
16 Sep 2022, 16:18:53 UTC
Next filing
18 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACST Class A Common Shares 128,138 09 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACST Share Option (Right to Buy) 09 Sep 2022 Class A Common Shares 75,000 $0.8900 Direct F1, F2
holding ACST Share Option (Right to Buy) 09 Sep 2022 Class A Common Shares 124,100 $1.63 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 75,000 Class A common shares underlying 75,000 share options granted on 06/22/2022. These share options vest on an even and quarterly basis over 36 months.
F2 Based on conversion of exercise price of C$1.15 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7727 on the date of grant.
F3 Represents 124,100 Class A common shares underlying 124,100 share options granted on 11/12/2021. These share options vest on an even and quarterly basis over 36 months.
F4 Based on conversion of exercise price of C$2.05 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7959 on the date of grant.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney